News & Updates
Showing Psychiatry articles
Showing

Donanemab delays Alzheimer's disease progression over 3 years
Donanemab administered for a limited duration continues to slow clinical progression in patients with early symptomatic Alzheimer’s disease (AD) over 3 years, according to Professor Chaur-Jong Hu of the Department of Neurology, Taipei Medical University, who spoke at Advances in Medicine (AIM) 2026.
Donanemab delays Alzheimer's disease progression over 3 years
04 Jun 2026
Malnutrition prevalence in older adults stresses need for early nutritional intervention
Older adults are no strangers to malnutrition, which has been shown to be associated with chronic diseases and geriatric syndromes such as depression, frailty, sarcopenia, polypharmacy, cognitive impairment, and functional dependence, according to a study.
Malnutrition prevalence in older adults stresses need for early nutritional intervention
03 Jun 2026
Blood test detects signs of Alzheimer’s disease in midlife
Blood test can identify signs of accumulation of highly accurate Alzheimer’s Disease (AD)–associated biomarkers in the brains of middle-aged adults, a large community-based cohort study has shown.
Blood test detects signs of Alzheimer’s disease in midlife
02 Jun 2026
Diet, exercise help improve erectile function
Adult men with erectile dysfunction may benefit from diet- and exercise-based interventions, which in a recent study have shown to yield modest but significant improvements in erectile function.





